Skip to main content

Molecular and immunological characterization of allergens from the entomopathogenic fungus Beauveria bassiana



Entomopathogenic fungi such as Beauveria bassiana are considered promising biological control agents for a variety of arthropod pests. Beauveria species, however, have the potential to elicit allergenic reactions in humans, although no specific allergens have been characterized to date.


Four putative allergens were identified within B. bassiana expressed sequence tag (EST) datasets. IgE-reactivity studies were performed using sera from patients displaying mold allergies against recombinant B. bassiana proteins expressed in E. coli.


Full length cDNA and genomic nucleotide sequences of four potential B. bassiana allergens were isolated. BLASTX search results led to their putative designation as follows; Bb-Eno1, with similarity to fungal enolases; Bb-f2, similar to the Aspergillus fumigatus major allergen, Asp f2 and to a fibrinogen binding mannoprotein; Bb-Ald, similar to aldehyde dehydrogenases; and Bb-Hex, similar to N-acetyl-hexosaminadases. All four genes were cloned into E. coli expression systems and recombinant proteins were produced. Immunoblots of E. coli extracts probed with pooled as well as individual human sera from patients displaying mould allergies demonstrated IgE reactivity versus recombinant Bb-Eno1 and Bb-Ald.


Four putative Beauveria bassiana allergens were identified. Recombinant proteins corresponding to two of the four, Bb-Eno1 and Bb-Ald were bound by sera IgEs derived from patients with fungal allergies. These data confirm the potential allergenicity of B. bassiana by identification of specific human IgE reactive epitopes.


Allergic diseases represent a growing human health problem, affecting up to 25% of individuals living in industrialized nations [1]. Both in- and outdoor populations of filamentous fungi are a major cause of human allergies and asthma, and can in some cases, lead to severe allergic disease [2]. Overall, some 30% of asthma cases can be attributed to exposure and sensitization to filamentous fungal allergens [35].

Beauveria bassiana is an entomopathogenic fungi currently under intensive study as a biological control agent against a wide range of agricultural, nuisance, and disease carrying insect pests [610]. B. bassiana is considered non-pathogenic to vertebrates, has not been deemed a potential health or environmental hazard [11], and has received EPA approval for commercial use. Volumetric assays of allergens performed in the Netherlands in the 1980's, revealed that although the environmental concentration of Beauveria spores was very low, the allergic response was quite high [12, 13]. Using skin prick assays on patients with mold allergies, B. bassiana was shown to elicit one of the strongest reactions relative to the other fungal species tested. More recently, it has been confirmed that crude extracts of B. bassiana can elicit allergic reactions in humans [14]. Sera IgEs derived from patients displaying allergies to molds as well as from people with no known allergies reacted with several proteins present in B. bassiana crude extracts. Many of these proteins were cross reactive with epitopes present in a number of major allergenic fungi, however the identities of any specific B. bassiana allergen has yet to be reported. In order to gain more information concerning B. bassiana and its potential allergenicity it is important to isolate the genes coding for IgE-binding allergens and characterize their protein products. Recombinant purified allergens, as compared to crude fungal extracts, can then be used to examine the nature of the IgE binding as well as in the diagnosis of allergy, in that the recombinant proteins are more standardized, can be highly purified, and hence are more suitable for immunodiagnosis [15, 16].

A significant number of fungal allergens are proteins of unknown function, although the biochemical activities of a number of allergens have been characterized. These typically fall into several classes including metabolic enzymes, proteases, and enzyme inhibitors [5, 17]. A molecule identified as an allergen in one species of fungus is often found to be an allergen when identified in other species, presumably due to similarities in structure and hence IgE-reactive epitopes. Thus, aldehyde dehydrogenase has been identified as an allergen in both Alternaria alternata (Alt a10) and Cladosporium herbarum (Cla h3) [18]. Amongst other metabolic enzymes, enolases (2-phosho-D-glycerate hydrolase) from a wide range of organisms, are common allergens with shared epitopes [1921]. This phenomenon of cross-reactivity of an IgE produced in response to an antigen from one organism to another can lead to wide spectrum allergic reactions derived from the original sensitization [2224].

Here we report the identification of four B. bassiana proteins as potential allergens. Full length cDNA and genomic nucleotide sequences of the four genes were determined. Similarity search results of the translated open reading frames of the proteins coded by the genes have led to their putative designation as follows; Bb-Eno1, an enolase; Bb-Ald, aldehyde dehydrogenase; Bb-f2, similar to Asp f2 and a fibrinogen binding mannoprotein; and Bb-Hex, an N-acetylhexosaminidase. The cDNA sequences of the proteins were used to design primers for subcloning of the genes into E. coli expression vectors. All four proteins were expressed as recombinant proteins in E. coli. Two of these proteins, Bb-Eno1 and Bb-Ald reacted with human IgEs derived from patients displaying mold allergies.


Strains and cultures

Beauveria bassiana (ATCC 90517) was maintained on Potato dextrose (PD) agar at 26°C. E. coli stains TOPO Top10 (Invitrogen, CA) and BL21 Rosetta (DE3), harboring the pRARE plasmid (Novagen, Darmstadt, Germany) were used for routine cloning and protein expression, respectively. E. coli strains were grown in Luria-Bertani (LB) nutrient broth or agar plates supplemented with the appropriate antibiotics as indicated.

Bioinformatic identification of putative allergen genes

Construction and sequencing of expressed sequence tagged (EST) cDNA libraries derived from five different developmental stages of B. bassiana has recently been reported [25, 26]. Additional sequences were obtained by suppressive subtractive hybridization (SSH) using fungal cells grown on insect cuticles and fungal cells grown on glucose as the tester and driver mRNAs respectively using established protocols [27, 28]. BLASTX similarity searches using the sequence dataset (~18,000 ESTs) revealed four sequences with high homology to allergen genes.

Molecular manipulations

Molecular manipulations including plasmid isolation, restriction digestion, agarose-gel electrophoresis, and PCR were performed using standard methods. Template mRNA was extracted from B. bassiana grown on minimal medium (per L; 0.4 g KH2PO4, 1.4 g Na2HPO4, 0.6 g MgSO4-7H2O, 1.0 g KCl, 0.25 g NH4NO3, 0.01 mg FeSO4) supplemented with 0.1% N-acetylglucosamine and 10% sterilized insect cuticle (mole cricket, Scapteriscus abbreviatus). Cultures were inoculated with 105 conidia/ml and grown with aeration for 6 d at 25°C. Fungal cells were lysed by grinding in liquid nitrogen and total RNA was extracted using RNAWiz (Ambion). cDNA libraries were constructed using the SMART RACE cDNA Amplification kit (Clontech, CA) according to manufacturer instructions. For construction of E. coli expression plasmids, an NdeI restriction site was incorporated into the forward primer and an EcoRI site into the reverse primer. PCR products were cloned directly into TOPO 2.1 using TOPO TA cloning system and transformed into TOPO Top 10 E. coli cells (Invitrogen, Carlsbad, CA). The TOPO 2.1 constructs were used for subcloning into the NdeI-EcoRI sites of pET43.1a (Novagen, Darmstadt, Germany) for expression using E. coli BL21 host strain harboring the pRARE plasmid.

Protein expression, Western and immunoblotting

Overnight cultures of E. coli BL21 harboring pRARE along with each respective pET43.1a based construct were grown in 3 ml of LB (supplemented with 50 μg/ml ampicillin and 12 μg/ml chloramphenicol) at 37°C with aeration. Fresh media (5–10 ml) was inoculated with aliquots (0.1–0.2 ml) of the overnight culture, and samples were incubated at 37°C with aeration to an OD600 = 0.6–0.8. T7 polymerase based expression of the recombinant proteins was initiated by the addition of 1–1.5 mM (final concentration) isopropyl-β-D-thiogalactopyranoside (IPTG), and cultures were returned to the incubator for an additional 2–3 hours. For extract preparation, cells were harvested by centrifugation (10,000 × g, 10 min) and the resultant pellet resuspended in 0.5 volumes TE (40 mM Tris, 1 mM EDTA, 0.01% phenylmethylsulfonyl fluoride (PMSF)). Cells were lysed by sonication (3 × 30 sec) on ice, after which samples were centrifuged (10,000 × g, 10 min) and separated into soluble and pellet (containing potential inclusion bodies) fractions. Samples of the crude soluble and pellet extracts were denatured with 4× LDS loading dye (Invitrogen) and boiled for 1–5 min prior to separation by SDS-Polyacrylamide gel electrophoresis (PAGE) using the Invitrogen NUPage-MOPS buffer system (10–12% Bis-tris polyacrylamide gels) according to the manufacture's recommended protocols. Gels were stained with Coomasie Blue R250 followed by destaining with 10% methanol, 10% acetic acid solution. For Western blots and immunodetection, samples were analyzed by SDS-PAGE as described above, followed by electroblotting to polyvinylidene-fluoride (PVDF) membranes (Invitrogen). After blocking (TBST; 25 mM Tris-HCl buffer saline containing 0.1% Tween-20 and 10% dry fat free milk), membrane were probed with either individual or pooled human sera as the primary antibody solution. Typically, sera were diluted in blocking buffer and incubated with membranes overnight at 4–8°C with gentle agitation. Membranes were washed 3 × using 50 ml TBST for 15 min each. Binding of human IgEs was visualized using a horseradish peroxidase (HRP) conjugated goat anti-human IgE (polyclonal) secondary antibody (BioSource International, CA). Membranes were incubated in secondary antibody (diluted 1:10,000 in blocking buffer) for 1 hr at room temperature, with gentle agitation. After secondary antibody incubation membranes were washed 3 times using 50 ml TBST and bands visualized using the Immuno-Star HRP detection system (Bio-Rad, Hercules, CA). Total protein membrane staining was performed using Ponceau S (Sigma, St. Louis, MO).

Analysis programs

Nucleotide manipulations and phylogenetic analyses were performed using multiple software programs. Initial sequence alignments were performed with ClustalW [29]. Alignment files (in Nexus format) were transferred to Splitstree for analysis and construction of phylograms, with typical bootstrap parameters set to 1000 [30].

Genbank submission

The isolated cDNA and genomic sequences of the four B. bassiana genes have been submitted to Genbank with the following accession numbers; Bb-Eno1, DQ767719; Bb-f2, DQ767720; Bb-Ald, DQ767722; and Bb-Hex, DQ767722.


Molecular characterization of four putative B. bassiana allergens

EST (Expressed sequence tag) panning and screening of a suppressive subtractive library (SSH) identified gene fragments of four potential allergens by sequence homology. The B. bassiana genes were designated as follows: Bb-Eno1, similar to Cladosporium herbarum enolase Cla h 6 [18]; Bb-f2, similar to Aspergillus fumigatus major allergen Asp f2 [31]; Bb-Ald, similar to C. herbarum allergen Cla h 3, an aldehyde dehydrogenase [18]; and Bb-Hex, with similarity to numerous fungal N-acetylhexosaminidases, including the Penicillium chrysogenum Pen ch 20 allergen [32].

Since the nucleotide fragments (200–300 bp) represented only a portion of the entire gene sequence coding for each protein, full length sequences were obtained by 5' and 3' RACE PCR as needed. These results were used to assemble the full length cDNA nucleotide sequences of the four genes. Separate sets of primers were then designed for amplification of the genomics DNA sequences of the genes and for cloning into the E. coli pET43a-based protein expression system as described in the Methods section. The lengths of the cloned cDNA and genomic sequences, the number of introns, along with an analysis of the predicted ORFs, detailing the number of amino acids, molecular mass, and pIs of the deduced B. bassiana proteins are given in Table 1. Top BLASTX search results for each protein are also presented (Table 2).

Table 1 Characteristics of the cloned B. bassiana genes and their predicted protein products
Table 2 BLASTX search results using full-length B. bassiana sequences

The genomic sequence of Bb-Eno1 consisted of 1548 bp from the start site to the stop codon and contained four introns. The lengths of the introns were between 52–69 bp and were located in the first half of the gene. The cDNA sequence of the open reading frame of Bb-Eno1 consisted of 1317 bp, constituting a protein of 438 amino acids with a calculated molecular mass ~47 kDa. BLASTX similarity searches of the complete Bb-Eno1 amino acid sequence against the NCBI protein database confirmed the initial observation, resulting in high similarity to enolases derived from numerous fungal species, including A. fumigatus, Penicillium citrinum, Alternaria alternata, and C. herbarum.

The genomic sequence of Bb-f2 consisted of 845 bp (start to stop codon) and contained one intron that began at bp 412 and was 59 bp in length. The coding sequence of Bb-F2 consisted of 261 amino acids, with a calculated molecular mass of 28 kDa. BLASTX similarity searches confirmed that Bb-f2 displayed high sequence similarity to the A. fumigatus major allergen Asp f 2.

The Bb-Ald genomic clone contained two introns; the first 106 bp in length, 62 bp from the ATG start codon, and the second, 59 bp in length, starting 568 bp from the start codon. The total size of the genomic clone was 1659 bp (start to stop codon), with the cDNA sequence consisting of 1494 bp coding for a proteins comprised of 497 amino acids with a calculated molecular mass of 53 kDa. BLASTX similarity searches using the complete Bb-Ald sequence as the query revealed similarity to aldehyde dehydrogenases, including those from A. alternata and C. herbarum.

The genomic clone corresponding to Bb-Hex was 1959 bp in length (start to stop codon) and did not contain any introns. The open reading frame coded for a protein consisting of 652 amino acids with a calculated molecular mass of 72 kDa. BLASTX similarity searches confirmed high sequence similarity to fungal N-acetylhexosaminidases.

Expression of recombinant B. bassiana proteins

The coding sequences of the four B. bassiana genes were subcloned into the pET43.1a expression vector as described in the Methods. The integrity of all clones was verified by sequencing of the inserts. The recombinant B. bassiana proteins were expressed in E. coli strain BL21 harboring the pRARE plasmid that contains the genes for the expression of rare tRNAs (Fig. 1, initial experiments using a BL21 strain lacking the pRARE plasmid resulted in little to no expression). Fractionation of the crude extracts into soluble and insoluble (presumably inclusion bodies) fractions revealed the B. bassiana proteins to be largely in the insoluble fraction (Fig. 2). In some instances, induction of the pET:Bb-Eno1 clone by IPTG resulted in the production of two bands, the first having the expected mass of 47 kDa and a second smaller band with a mass ≈45 kDa (Fig 1, lane 2). Similarly, the Bb-F2 clone also appeared to produce two protein bands of ≈28 kDa (Figure 1, lane 4). Further experimentation revealed that these bands were due to cleavage during heat denatuation (Fig 3).

Figure 1
figure 1

SDS-PAGE analysis of B. bassiana recombinant proteins expressed in E. coli. SDS-PAGE, Coomasie Blue stained, extracts of E. coli strain BL21 harboring pRARE and the indicated expression plasmid constructs; lanes 1) and 2); pET41a:Bb-Eno1, lanes 3) and 4) pET41a:Bb-f2, lanes 5) and 6) pET41a:Bb-Ald, lanes 7) and 8) pET41a:Bb-Hex. Uninduced cell cultures, lanes 1), 3), 5), and 7). IPTG induced cell cultures, lanes 2), 4), 6), and 8).

Figure 2
figure 2

SDS-PAGE analysis of soluble and pellet (inclusion bodies) fractions of the B. bassiana proteins expressed in E. coli. SDS-PAGE, Coomasie Blue stained extracts of soluble fractions lanes 1), 3), 5) and 7), and pellet fractions, lanes 2), 4), 6), and 8). Expression of Bb-Eno1, lanes 1) and 2), Bb-f2, lanes 3) and 4), Bb-Ald, lanes 5) and 6), and Bb-Hex, lanes 7) and 8).

Figure 3
figure 3

SDS-PAGE analysis of the temperature sensitivity of the recombinant B. bassiana proteins. SDS-PAGE, Coomasie Blue stained, E. coli crude extracts subjected to; 1 min heat denaturation at 95°C, panel A), 5 min, 95°C, panel B), and 20 min, 95°C, panel C), Lanes correspond to crude extracts containing, lane 1) Bb-Eno1, lane 2) Bb-f2, lane 3) Bb-Ald, and lane 4) Bb-Hex.

IgE immunoblot analysis of recombinant proteins

Immunoblots were used in order to determine whether human IgEs could bind the recombinant B. bassiana proteins. Crude E. coli extracts containing the expressed proteins were resolved by SDS-PAGE and transferred to PVDF membranes as described in the Methods. Initial experiments were performed using blots containing the four expressed proteins as well as a crude B. bassiana extract (positive control), that were probed with one of two sera pools containing serum from ten patients each, pools A-J and K-T (Fig. 4). Each blot was treated with 0.2 ml of each serum (1:35 dilution, final concentration). The blot probed with pool A-J revealed strong IgE binding of the two protein bands corresponding to BbEno1, as well as several reactive (background) E. coli bands. The B. bassiana crude extract reacted with a variety of IgEs present in the sera as has been previously reported. From the sera tested, faint IgE binding to Bb-Ald was noted, with no visible IgE binding observed for Bb-f2 and Bb-Hex. Control blots using E. coli crude extracts derived from cells harboring the vector with no insert resulted in essentially the same background bands as seen with extracts containing the expressed proteins.

Figure 4
figure 4

Immunoblot analysis of recombinant B. bassiana proteins. Immunoblots were probed with sera pooled from (10 each) patients displaying mold allergies as indicated on the panels (A-J, and K-T). The final concentration of individual sera in each pool was 1:35. An HRP conjugated goat anti-human IgE antibody was used as the secondary antibody. Lanes contain recombinant E. coli expressed proteins as follows, lane 1) Bb-Eno1, 2) Bb-f2,. 3) Bb-Ald, 4) Bb-Hex. Lane 5) 40 μg crude B. bassiana extract.

In order to confirm the binding of IgEs to Bb-Ald, additional experiments using smaller sera pools and higher final concentrations of individual sera were performed. Five sera pools, each containing 1:5 dilutions of two sera, and designated as AB, CD, EF, GH, IJ, KL, MN, OP, QR, and ST were created. In one set of experiments pools AB, CD, EF, GH, and IJ were then used to probe membranes containing Bb-Eno1, Bb-f2, and Bb-Ald, (Fig. 5, Bb-Hex was omitted due to the lack of reactivity in preliminary experiments). These results confirmed IgE binding to Bb-Eno1 (strong signal from pools AB and EF, with weaker signal from pool GH) and to Bb-Ald (pools AB and GH). Not too surprisingly, IgE binding of "background bands", i.e. antigens derived from the E. coli extracts were highly variable between pools. Using these sera pools, no IgE binding was observed to Bb-f2. In a second series of experiments the pools were used to probe membrane strips containing only Bb-Ald extracts. IgE binding of Bb-Ald was noted using pools AB, GH, OP, and ST (Fig. 6). Since pool AB resulted in strong signals to both Bb-Eno1 and Bb-Ald, further experiments were performed using the individual sera (either A or B) to probe membranes containing all four B. bassiana recombinant proteins (Fig 7). These results revealed that serum A contained IgEs that bound to Bb-Eno1 and Bb-Ald, whereas serum B contained IgEs reactive only to Bb-Eno1.

Figure 5
figure 5

Immunoblot analysis of recombinant B. bassiana proteins. Immunoblots were probed with sera pools (2 each) as indicated on the panels (AB, CD, EF, GH, and IJ), with a 1:5 final concentration of individual sera in each pool. Blots were probed with an HRP conjugated goat anti-human IgE antibody as the secondary antibody. Lanes contain recombinant E. coli expressed proteins as follows, lane 1) Bb-Eno1, 2) Bb-f2,. 3) Bb-Ald.

Figure 6
figure 6

Immunoblot analysis of recombinant Bb-Ald. PVDF membrane strips containing crude extracts of E. coli expressed Bb-Ald were probed with 1 mL of each designated sera pool, with each pool containing two sera (final dilution 1:5 each sera). Arrow indicates the position of Bb-Ald.

Figure 7
figure 7

Ponceau S staining and immunoblot analysis of recombinant B. bassiana. Immunoblots were probed with individual sera, A) and B) as indicated on the panels using a 1:5 final concentration of sera. Blots were probed with an HRP conjugated goat anti-human IgE antibody as the secondary antibody. Lanes contain recombinant E. coli expressed proteins as follows, lane 1) Bb-Eno1, 2) Bb-f2,. 3) Bb-Ald, and 4) Bb-Hex. Panel 1) represents Ponceau S staining of the PVDF membrane after transfer.

Phylogenetic analyses

Bb-Eno1 displayed high sequence similarity to fungal enolases several of which are known allergens. A phylogram was constructed using the amino acid sequences of 21 fungal enolases as well as those of Drosophila melanogaster, E. coli, and the rubber plant, Hevea brasiliensis, a known potent allergen (Fig. 8). Of the enolases examined, nine have been identified as allergens (designated with an asterisk in the figure). These proteins do not appear to cluster in any discernable pattern and are equally distributed throughout the phylogram. Similarly, an analysis of the available fungal aldehyde dehydrogenases failed to reveal any discernable pattern or clustering of the known allergens.

Figure 8
figure 8

Full length amino acid sequences of 24 enolases deposited in the NCBI Genbank database were used to construct an enolase phylogram. Normalized posterior probabilities values greater than or equal to 0.9 are presented at their respective nodes. Known allergenic enolases are denoted by an asterisk.


Allergy is a hypersensitive response of the immune system and fungi are important triggers of respiratory and other forms of allergies [5, 3335]. As alternatives to chemical pesticides, entomopathogenic fungi such as Metarhizium anisopliae and Beauveria bassiana hold promise as biological control agents, and both organisms have been EPA approved for commercial control of a variety of arthropod pests [811]. The process of fungal infection of insect targets involves the use of infectious propagules, typically (conidia) spores, which attach and germinate across host surfaces. Growing fungal cells then begin to penetrate the cuticle and proliferate within the insect body, ultimately resulting in the death of the host [6, 36, 37]. Use of these biological pesticides, however, is likely to lead to the dispersal of inhalable fungal particles. Several studies have demonstrated the potential of these fungi in eliciting allergic reactions. [12, 14, 38]. Some occupational allergy to M. anisopliae has been noted and immune and pulmonary responses characteristic of allergy were observed in Balb/c mice challenged with M. anisopliae extracts [39, 40]. Furthermore, allergen-triggered airway hyperresponsiveness and lung pathology occurred in mice sensitized with this fungus [41]. The allergenic potential of B. bassiana has been confirmed by intradermal skin testing, and numerous IgE reactive proteins, some of which are cross-reactive among allergens from other fungi have been noted in this organism [14]. To date, however, there have been no reports detailing the molecular identification of B. bassiana (or M. anisopliae) IgE-reactive antigens.

The present study describes the cloning and expression of four putative B. bassiana allergens and demonstrated IgE-reactivity for two of the recombinant proteins using sera derived from patients displaying mold allergies. Bb-Eno1 has a calculated monomer molecular mass of 47.4 kDa and displays similarity to enolases that form an extensively studied group of allergens. IgE cross reactivity between the enolases of C. herbarum, A. alternata, C. albicans, and A. fumigatus has been well characterized and it is likely that the B. bassiana protein would also be recognized by the same IgEs. Modeling of the C herbarum enolase using the solved crystal structure of the S. cerevisiae enolase was used to construct 10 recombinant peptides spanning the length of the C. herbarum enolase [42]. Six of these peptides, distributed throughout the entire length of the protein showed IgE-binding activity. One of the peptides encompassed a region that overlapped with the other 5 IgE reactive peptides and formed, based upon the modeling, an extended structure that twice spanned the body of the globular protein and reached the surface three times. This sequence was therefore deemed contain at least one immunodominant IgE epitope, and sequence analyses revealed a highly similar stretch of amino acids in the deduced B. bassiana enolase sequence. Approximately 20% of the sera tested (4–6/20) displayed positive IgE reactivity to the recombinant Bb-Eno1, indicating that this protein is likely to be a significant allergen in B. bassiana.

Bb-Ald was similar to the A. alternata Alt a 10 and C. herbarum Cla h 3 proteins, both of which have been characterized as aldehyde dehydrogenases [18]. In a survey of allergens recognized by patients with mold allergies, 2% displayed IgE reactivity to Alt a 10, whereas 36% displayed reactivity to Cla h 3 [18]. Based upon these results, Cla h 3 was classified as an important allergen and Alt a 10 as a minor allergen. Only one (out of twenty) of our sera displayed strong reactivity to Bb-Ald, indicating that this protein is indeed an allergen, however due to our small sample size, it is not possible to draw any definitive conclusions regarding the importance of this protein as a B. bassiana allergen.

Bb-f2 showed sequence homologies to the A. fumigatus Asp f2 major allergen and the fibrinogen binding protein from C. albicans [43]. In A. fumigatus, Asp f2 appears to be expressed as a 55-kDa mycelial glycoprotein as well as a 37-kDa culture filtrate presumably deglycosylated protein (the calculated molecular mass of Asp f2 is 29 kDa, the reason for the discrepancy is unclear but may be attributed to specific C-terminal amino acid residues), both of which are IgE reactive [31]. Asp f2 also appears to interact with extracellular matrix proteins such as laminin, and exhibited IgE binding from sera derived from patients with allergic bronchopulmonary aspergillosis (ABPA) and cyctic fibrosis-ABPA patients, but not from sera isolated from A. fumigatus-sensitized allergic asthma (and normal control subjects) [31]. Thus, the observed lack of IgE reactivity to Bb-f2 may be attributed to the lack of ABPA patients in our sera samples.

The original cDNA fragment corresponding to Bb-Hex displayed the highest similarity to the N-acetylhexosaminidase of P. chrysogenum (Pen ch 20), that has been identified as an allergen [32]. Subsequent, full length cDNA cloning and characterization resulted in higher similarity to other fungal hexosaminidases that have not been characterized as allergens (see E-values in Table 2). None of our sera samples displayed IgE reactivity to recombinant Bb-Hex, however, due to our low sample size the possibility cannot be excluded that this protein represents a B. bassiana allergen.

Our results confirm the potential allergenicity of B. bassiana by the molecular and immunological characterization of specific allergens from this organism and suggest that some precautions should be taken into account in biological control applications using entomopathogenic fungi. It is, however, important not to overstate the potential risks (versus benefits) and the overall safety with respect to allergenicity of these fungi may be similar to that of baker's yeast from which allergens, including enolase, have also been isolated [44, 45]. While it is not possible to determine the fraction of the total allergen production the four isolated proteins represents, immunoblot comparisons between the isolated proteins and the reactivity of crude B. bassiana extracts indicated the presence of numerous additional allergens that have yet to be characterized, some of which may represent more highly antigenic epitopes. The isolation of putative B. bassiana allergens described in this report relied upon identifying molecules by the resemblance of their DNA sequences to previously identified allergens and future experiments using alternate approaches (e.g. phage display [46]) may be needed to identify additional allergens. Finally, although much work has been performed in regards to isolating and characterizing fungal allergens, the roles of these proteins in fungal processes such as development and pathogenesis remains obscure. As a genetically amenable organism and a pathogen of arthropods, B. bassiana represents a novel system to examine the relationship between allergenicity and (insect) pathogenesis. Targeted gene-knockouts, for instance, can be used to probe affects upon virulence and interactions between specific allergen and arthropod innate immune systems.


Cloning, sequencing, and heterologous expression of four putative B. bassiana allergens was performed. Recombinant proteins corresponding to Bb-Eno1 and Bb-Ald, but not Bb-f2 and Bb-Hex, displayed IgEs reactivity against sera from patients with mold allergies. Due to the low sera sample numbers used, it cannot be excluded that Bb-f2 and Bb-Hex are allergens, and further testing is warranted. Bb-Eno1 was similar to enolases that represent a well characterized group of major allergens. Bb-Ald was similar to aldehyde dehydrogenases that are considered major allergens in some fungal species, but minor allergens in others. The molecular identification of B. bassiana allergens can lead diagnostic methods for determining sensitization to this organism and provides a rational basis for allergen attenuation in order to yield safer biological control products. The B. bassiana-arthropod interaction may represent a novel model system to examine the relationships between allergenicity and pathogenicity.



allergic bronchopulmonary aspergillosis


basic local alignment search tool


Environmental Protection Agency


expect score


ethylenediaminetetraacetic acid


expressed sequence tags


horseradish peroxidase


immunoglobulin E




Luria-Bertani broth


National Center for Biotechnology Information


polyacrylamide gel electrophoresis


polymerase chain reaction


phenylmethyl sulfonyl fluoride


polyvinylidene fluoride


rapid amplification of cDNA ends


sodium duodecyl sulfate


suppressive subtractive hybridization


Tris buffered saline.


  1. Chiu AM, Fink JN: Fungal allergy and pathogenicity. Introduction. Chem Immunol. 2002, 81: 1-4.

    Article  PubMed  Google Scholar 

  2. Kurup VP, Shen HD, Banerjee B: Respiratory fungal allergy. Microbes Infect. 2000, 2: 1101-1110. 10.1016/S1286-4579(00)01264-8

    Article  CAS  PubMed  Google Scholar 

  3. Vijay HM, Kurup VP: Fungal allergens. Clin Allergy Immunol. 2004, 18: 223-249.

    CAS  PubMed  Google Scholar 

  4. Wuthrich B: Epidemiology of the allergic diseases: are they really on the increase? Int Arch Allergy Appl Immunol. 1989, 90 Suppl 1: 3-10.

    CAS  PubMed  Google Scholar 

  5. Kurup VP, Shen HD, Vijay H: Immunobiology of fungal allergens. Int Arch Allergy Immunol. 2002, 129: 181-188. 10.1159/000066780

    Article  CAS  PubMed  Google Scholar 

  6. Shah PA, Pell JK: Entomopathogenic fungi as biological control agents. Appl Microbiol Biotechnol. 2003, 61: 413-423.

    Article  CAS  PubMed  Google Scholar 

  7. Wraight SP, Ramos M: Application parameters affecting efficacy of Beauveria bassiana foliar treatments against Colorado potato beetle, Leptinotarsa decemlineata. Biological Control. 2002, 23: 164-178. 10.1006/bcon.2001.1004.

    Article  Google Scholar 

  8. Wraight SP, Jackson MA, de Kock SL: Production, stabilization, and formulation of fungal biocontrol agenets. In Fungi as Biocontrol Agents: Progress Problems, and Potential Edited by: Butt TM, Jackson C and Magan N. Wallingford, UK, CAB International, 2001: 253-287.

    Chapter  Google Scholar 

  9. McCoy CW: Entomogenous fungi as microbial pestidides. In New Directions in Biological Control Edited by: Baker RR and Dunn PE. New York, NY, A.R. Liss, 1990, 139-159.

    Google Scholar 

  10. Leathers TD, Gupta SC, Alexander NJ: Mycopesticides: status, challenges, and potential. J Indust Microbiol. 1993, 12: 69-75. 10.1007/BF01569904.

    Article  Google Scholar 

  11. Goettel MS, Hajek AE, Siegel JP, Evans HC: Safety of fungal biocontrol agents. In Fungi as biocontrol agents, progress, problems, and potential Edited by: Butt TM, Jackson C and Magan N. Wallingford, UK, CAB International, 2001, 347-375.

    Chapter  Google Scholar 

  12. Beaumont F, Kauffman HF, de Monchy JG, Sluiter HJ, de Vries K: Volumetric aerobiological survey of conidial fungi in the North-East Netherlands. II. Comparison of aerobiological data and skin tests with mould extracts in an asthmatic population. Allergy. 1985, 40: 181-186.

    Article  CAS  PubMed  Google Scholar 

  13. Beaumont F, Kauffman HF, Sluiter HJ, de Vries K: A volumetric-aerobiologic study of seasonal fungus prevalence inside and outside dwellings of asthmatic patients living in northeast Netherlands. Ann Allergy. 1984, 53: 486-492.

    CAS  PubMed  Google Scholar 

  14. Westwood GS, Huang SW, Keyhani NO: Allergens of the entomopathogenic fungus Beauveria bassiana. Clin Mol Allergy. 2005, 3: 1. 10.1186/1476-7961-3-1

    Article  PubMed Central  PubMed  Google Scholar 

  15. Valenta R, Vrtala S, Laffer S, Spitzauer S, Kraft D: Recombinant allergens. Allergy. 1998, 53: 552-561.

    Article  CAS  PubMed  Google Scholar 

  16. Valenta R, Almo S, Ball T, Dolecek C, Steinberger P, Laffer S, Eibensteiner P, Flicker S, Vrtala S, Spitzauer S, Valent P, Denepoux S, Kraft D, Banchereau J, Lebecque S: The immunoglobulin E-allergen interaction: a target for therapy of type I allergic diseases. Int Arch Allergy Immunol. 1998, 116: 167-176. 10.1159/000023942

    Article  CAS  PubMed  Google Scholar 

  17. Stewart GA, Thompson PJ, McWilliam AS: Biochemical properties of aeroallergens: contributory factors in allergic sensitization? Pediatr Allergy Immunol. 1993, 4: 163-172.

    Article  CAS  PubMed  Google Scholar 

  18. Achatz G, Oberkofler H, Lechenauer E, Simon B, Unger A, Kandler D, Ebner C, Prillinger H, Kraft D, Breitenbach M: Molecular cloning of major and minor allergens of Alternaria alternata and Cladosporium herbarum. Mol Immunol. 1995, 32: 213-227. 10.1016/0161-5890(94)00108-D

    Article  CAS  PubMed  Google Scholar 

  19. Breitenbach M, Simon B, Probst G, Oberkofler H, Ferreira F, Briza P, Achatz G, Unger A, Ebner C, Kraft D, Hirschwehr R: Enolases are highly conserved fungal allergens. Int Arch Allergy Immunol. 1997, 113: 114-117.

    Article  CAS  PubMed  Google Scholar 

  20. Sharma V, Gupta R, Jhingran A, Singh BP, Sridhara S, Gaur SN, Arora N: Cloning, recombinant expression and activity studies of a major allergen "enolase" from the fungus Curvularia lunata. J Clin Immunol. 2006, 26: 360-369. 10.1007/s10875-006-9032-4

    Article  CAS  PubMed  Google Scholar 

  21. Simon-Nobbe B, Probst G, Kajava AV, Oberkofler H, Susani M, Crameri R, Ferreira F, Ebner C, Breitenbach M: IgE-binding epitopes of enolases, a class of highly conserved fungal allergens. J Allergy Clin Immunol. 2000, 106: 887-895. 10.1067/mai.2000.110799

    Article  CAS  PubMed  Google Scholar 

  22. Horner WE, Helbling A, Salvaggio JE, Lehrer SB: Fungal allergens. Clin Microbiol Rev. 1995, 8: 161-179.

    PubMed Central  CAS  PubMed  Google Scholar 

  23. Aukrust L, Borch SM: Cross reactivity of moulds. Allergy. 1985, 40: 57-60.

    Article  PubMed  Google Scholar 

  24. Aalberse RC, Akkerdaas J, van Ree R: Cross-reactivity of IgE antibodies to allergens. Allergy. 2001, 56: 478-490. 10.1034/j.1398-9995.2001.056006478.x

    Article  CAS  PubMed  Google Scholar 

  25. Cho EM, Boucias D, Keyhani NO: EST analysis of cDNA libraries from the entomopathogenic fungus Beauveria (Cordyceps) bassiana. II. Fungal cells sporulating on chitin and producing oosporein. Microbiology. 2006, 152: 2855-2864. 10.1099/mic.0.28845-0

    Article  CAS  PubMed  Google Scholar 

  26. Cho EM, Liu L, Farmerie W, Keyhani NO: EST analysis of cDNA libraries from the entomopathogenic fungus Beauveria (Cordyceps) bassiana. I. Evidence for stage-specific gene expression in aerial conidia, in vitro blastospores and submerged conidia. Microbiology. 2006, 152: 2843-2854. 10.1099/mic.0.28844-0

    Article  CAS  PubMed  Google Scholar 

  27. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD: Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 1996, 93: 6025-6030. 10.1073/pnas.93.12.6025

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Diatchenko L, Lukyanov S, Lau YF, Siebert PD: Suppression subtractive hybridization: a versatile method for identifying differentially expressed genes. Methods Enzymol. 1999, 303: 349-380.

    Article  CAS  PubMed  Google Scholar 

  29. Higgins DG, Thompson JD, Gibson TJ: Using CLUSTAL for multiple sequence alignments. Methods Enzymol. 1996, 266: 383-402.

    Article  CAS  PubMed  Google Scholar 

  30. Huson DH, Bryant D: Application of phylogenetic networks in evolutionary studies. Mol Biol Evol. 2006, 23: 254-267. 10.1093/molbev/msj030

    Article  CAS  PubMed  Google Scholar 

  31. Banerjee B, Greenberger PA, Fink JN, Kurup VP: Immunological characterization of Asp f 2, a major allergen from Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. Infect Immun. 1998, 66: 5175-5182.

    PubMed Central  CAS  PubMed  Google Scholar 

  32. Shen HD, Liaw SF, Lin WL, Ro LH, Yang HL, Han SH: Molecular cloning of cDNA coding for the 68 kDa allergen of Penicillium notatum using MoAbs. Clin Exp Allergy. 1995, 25: 350-356. 10.1111/j.1365-2222.1995.tb01053.x

    Article  CAS  PubMed  Google Scholar 

  33. Aukrust L: Mold allergy. Introduction. Clin Rev Allergy. 1992, 10: 147-151.

    CAS  PubMed  Google Scholar 

  34. Einarsson R, Aukrust L: Allergens of the fungi imperfecti. Clin Rev Allergy. 1992, 10: 165-190.

    CAS  PubMed  Google Scholar 

  35. Levetin E, Horner WE: Fungal aerobiology: exposure and measurement. Chem Immunol. 2002, 81: 10-27.

    Article  PubMed  Google Scholar 

  36. Khachatourians GG: Biochemistry and Molecular Biology of Entomopathogenic Fungi. In The Mycota VI: Human and Animal Relationships Edited by: Howard DH and Miller JD. Berlin, Heidelberg, Springer-Verlag, 1996, 331-363.

    Chapter  Google Scholar 

  37. Hajek AE, St Leger RJ: Interactions between fungal pathogens and insect hosts. Annual Rev Entomol. 1994, 39: 293-322. 10.1146/annurev.en.39.010194.001453.

    Article  Google Scholar 

  38. Beaumont F, Kauffman HF, Sluiter HJ, De Vries K: Sequential sampling of fungal air spores inside and outside the homes of mould-sensitive, asthmatic patients: a search for a relationship to obstructive reactions. Ann Allergy. 1985, 55: 740-746.

    CAS  PubMed  Google Scholar 

  39. Kaufman G, Bellas T: Occupational allergy to Metarhizium. Allergy Asthma Proc. 1996, 17: 166.

    Google Scholar 

  40. Ward MD, Sailstad DM, Selgrade MK: Allergic responses to the biopesticide Metarhizium anisopliae in Balb/c mice. Toxicol Sci. 1998, 45: 195-203. 10.1006/toxs.1998.2479

    CAS  PubMed  Google Scholar 

  41. Ward MD, Madison SL, Sailstad DM, Gavett SH, Selgrade MK: Allergen-triggered airway hyperresponsiveness and lung pathology in mice sensitized with the biopesticide Metarhizium anisopliae. Toxicology. 2000, 143: 141-154. 10.1016/S0300-483X(99)00166-3

    Article  CAS  PubMed  Google Scholar 

  42. Breitenbach M, Simon-Nobbe B: The allergens of Cladosporium herbarum and Alternaria alternata. Chem Immunol. 2002, 81: 48-72.

    Article  CAS  PubMed  Google Scholar 

  43. Banerjee B, Kurup VP: Molecular biology of Aspergillus allergens. Front Biosci. 2003, 8: S128-39.

    Article  PubMed  Google Scholar 

  44. Baldo BA, Baker RS: Inhalant allergies to fungi: reactions to bakers' yeast (Saccharomyces cerevisiae) and identification of bakers' yeast enolase as an important allergen. Int Arch Allergy Appl Immunol. 1988, 86: 201-208.

    Article  CAS  PubMed  Google Scholar 

  45. Kortekangas-Savolainen O, Kalimo K, Lammintausta K, Savolainen J: IgE-binding components of baker's yeast (Saccharomyces cerevisiae) recognized by immunoblotting analysis. Simultaneous IgE binding to mannan and 46-48 kD allergens of Saccharomyces cerevisiae and Candida albicans. Clin Exp Allergy. 1993, 23: 179-184. 10.1111/j.1365-2222.1993.tb00879.x

    Article  CAS  PubMed  Google Scholar 

  46. Rhyner C, Weichel M, Fluckiger S, Hemmann S, Kleber-Janke T, Crameri R: Cloning allergens via phage display. Methods. 2004, 32: 212-218. 10.1016/j.ymeth.2003.08.003

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Nemat O Keyhani.

Additional information

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

GSW carried out the molecular, immunological, and other in vitro experiments, and participated in the design of the study. SWH participated in the design of the study and provided technical support for the project. NOK conceived of the study, participated in its design and coordination, and drafted the manuscript.

Authors’ original submitted files for images

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Westwood, G.S., Huang, SW. & Keyhani, N.O. Molecular and immunological characterization of allergens from the entomopathogenic fungus Beauveria bassiana. Clin Mol Allergy 4, 12 (2006).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: